These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12627664)

  • 21. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress.
    Hoffman M
    Med Hypotheses; 2011 Dec; 77(6):1088-93. PubMed ID: 21963358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
    De Caterina R; Zampolli A; Madonna R; Fioretti P; Vanuzzo D
    Ital Heart J; 2004 Jun; 5 Suppl 6():19S-24S. PubMed ID: 15185912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.
    Weiss N; Keller C; Hoffmann U; Loscalzo J
    Vasc Med; 2002 Aug; 7(3):227-39. PubMed ID: 12553746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinemia and thrombosis.
    Guba SC; Fonseca V; Fink LM
    Semin Thromb Hemost; 1999; 25(3):291-309. PubMed ID: 10443960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
    Caramia G; Belardinelli R
    Monaldi Arch Chest Dis; 2006 Dec; 66(4):275-85. PubMed ID: 17312847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperhomocysteinemia and cardiovascular disease in animal model.
    Azad MAK; Huang P; Liu G; Ren W; Teklebrh T; Yan W; Zhou X; Yin Y
    Amino Acids; 2018 Jan; 50(1):3-9. PubMed ID: 29018979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine impairs coronary artery endothelial function by inhibiting tetrahydrobiopterin in patients with hyperhomocysteinemia.
    He L; Zeng H; Li F; Feng J; Liu S; Liu J; Yu J; Mao J; Hong T; Chen AF; Wang X; Wang G
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1061-5. PubMed ID: 20858749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteine, intracellular signaling and thrombotic disorders.
    Dionisio N; Jardín I; Salido GM; Rosado JA
    Curr Med Chem; 2010; 17(27):3109-19. PubMed ID: 20629621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia as a risk factor for cardiovascular diseases. The association of hyperhomocysteinemia with diabetes mellitus and renal transplant recipients.
    Socha MW; Polakowska MJ; Socha-Urbanek K; Fiedor P
    Ann Transplant; 1999; 4(1):11-9. PubMed ID: 10850596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhomocysteinemia: a risk factor for arterial and venous thrombotic disease.
    Cattaneo M
    Int J Clin Lab Res; 1997; 27(3):139-44. PubMed ID: 9352375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild hyperhomocysteinemia: risk factor or just risk predictor for cardiovascular diseases?
    Weiss N; Hilge R; Hoffmann U
    Vasa; 2004 Nov; 33(4):191-203. PubMed ID: 15623193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperhomocysteinemia as a clinical manifestation of thrombosis risk].
    Kozlova TV
    Klin Med (Mosk); 2005; 83(2):9-12. PubMed ID: 15803823
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyperhomocysteinemia--a risk factor for development of occlusive vascular diseases].
    Milosević-Tosić M; Borota J
    Med Pregl; 2002; 55(9-10):385-91. PubMed ID: 12584890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine as a risk factor for atherosclerosis.
    Temple ME; Luzier AB; Kazierad DJ
    Ann Pharmacother; 2000 Jan; 34(1):57-65. PubMed ID: 10669187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine and coronary microcirculation: is it a microvasculopathic agent?
    Turhan H; Aksoy Y; Yetkin E
    Int J Cardiol; 2006 Jun; 110(2):269-70. PubMed ID: 16325281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.